Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.
Marais C, Claude C, Semaan N, Charbel R, Barreault S, Travert B, Piloquet JE, Demailly Z, Morin L, Merchaoui Z, Teboul JL, Durand P, Miatello J, Tissières P; COVID-19 Immune Suppression (CLOVIS) Study Group.
Marais C, et al.
Ann Intensive Care. 2021 Jul 14;11(1):111. doi: 10.1186/s13613-021-00896-4.
Ann Intensive Care. 2021.
PMID: 34259942
Free PMC article.